Accelerate Brain Cancer Cure

Overview

Accelerate Brain Cancer Cure is a nonprofit organization with a for-profit mindset. In 2001, after Dan Case was diagnosed with brain cancer, he devoted his energy and passion to lend hope for brain cancer patients by working to accelerate a cure and increase the number of potential therapies discovered and move them rapidly into the clinic for patients. Dan, together with his brother, Steve Case, their families, leading entrepreneurs, scientists and researchers, founded ABC2.

Mission

To hasten the discovery of a cure for brain cancer.

Program

Through Research Award Grants, ABC2 provides innovative researchers with the support required to make critical translational breakthroughs.

ABC2 supports a Preclinical Screening Program at the Preston Robert Tisch Brain Tumor Center at Duke University which encourages the discovery and development of potential new and combination targeted therapies for patients at a rapidly accelerated pace.

As an independent, but collaborative force, ABC2 can identify specific areas for progress. ABC2 initiated and funds a Clinical Network, comprised of leading clinical investigators from four neuro-oncology centers (UCSF, UCLA, Preston Robert Tisch Brain Tumor Center at Duke University and M.D. Anderson ), to serve as a resource to accelerate the transition of therapies into clinical studies for patients.

ABC2 breaks-down the silos to convene medical/academia, industry and government in effort to increase strategic investments in brain cancer therapies and translational research. ABC2 uses its unique position to bring-together leaders in their respective fields to explore novel research that will speed new treatments to patients. These collaborations are focused on bringing new hope to brain cancer patients and uncovering the potential for treatments that might otherwise be overlooked.

Impact

Accelerate Brain Cancer Cure inspires new hope for a cure by using a results-driven business model to bring more treatments to patients, stimulate research & development and otherwise support the accelerated development of new therapies for brain cancer.

Countries of Operation

United States